• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

KRAS

bubbles on a pink background
Biotech

At ASCO, execs see chance to ‘rewrite textbooks’ in cancer care

Although ASCO's CEO started the meeting with a warning about Trump's proposed budget cuts, the mood didn't carry over for most attendees.
Gabrielle Masson Jun 2, 2025 9:45am
SPAC special purpose acquisition company

BridgeBio's cancer spinout backs SPAC as path to Nasdaq

Feb 28, 2025 9:25am
Stock exchange concept

High dose of Cardiff's KRAS drug shows 64% ORR, sending stock up

Dec 10, 2024 4:05pm
Stop sign

Roche culls cough candidate, pivots KRAS program in Q3 update

Oct 23, 2024 6:35am
china chinese Asia

Allist pays Jacobio $21M, landing role in Chinese KRAS race

Aug 30, 2024 9:12am
Sinking deal terminated sunk deal ends

Genentech sinks SHP2 pact, leaving Relay to race thinning field

Jul 17, 2024 8:01am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings